Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jul 8, 2016 at 10:05 AM EDT

Juno Therapeutics Stumbles Over FDA Clinical Hold

Juno Therapeutics saw its shares sink early on Friday after the U.S. Food and Drug Administration (FDA) levied a clinical…

Chris Lange | Jul 8, 2016 at 9:10 AM EDT

Eleven Biotherapeutics Soars on Investigational Milestone

Shares of Eleven Biotherapeutics saw a handy gain early on Friday after the company announced that its Investigational New Drug…

Chris Lange | Jul 7, 2016 at 12:40 PM EDT

PTC Therapeutics Wins on New DMD Agreement

PTC Therapeutics made waves on Thursday following a development in its nonsense mutation Duchenne muscular dystrophy (nmDMD) treatment.

Chris Lange | Jul 6, 2016 at 11:10 AM EDT

Why Flexion Therapeutics Is Adding 3 New Executives to Its Ranks

Flexion Therapeutics has announced that three new executives have joined the company in key marketing, medical affairs and market access…

Chris Lange | Jul 6, 2016 at 9:45 AM EDT

Do Confidentiality Agreements Signal an Impending Medivation Acquisition?

France-based Sanofi has been pursuing Medivation, but the company has been reluctant in responding to these offers. However things could…

Chris Lange | Jul 5, 2016 at 1:10 PM EDT

Amedica Gears Up for Secondary Offering

Amedica expects to gain about $11 million in gross proceeds from an underwritten secondary offering. The entire offering is valued…

Chris Lange | Jul 5, 2016 at 8:40 AM EDT

Insys Soars on Huge FDA Win

Insys Therapeutics announced that the FDA has approved its dronabinol oral solution, Syndros, for use in treating anorexia associated with…

Chris Lange | Jul 3, 2016 at 9:35 AM EDT

4 Companies That Destroyed Shareholders Despite a Brexit Recovery

Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Chris Lange | Jul 1, 2016 at 8:37 AM EDT

Why Array Is Making a Run

Array BioPharma Inc. (NASDAQ: ARRY) is watching its shares make a handy gain on Friday after making a key U.S.…

Chris Lange | Jun 30, 2016 at 1:42 PM EDT

Ampio Crashes After Late-Stage Trial Failure

Ampio Pharmaceuticals, Inc. (NYSEMKT: AMPE) is watching its shares get cut in half on Thursday after news of a failed…

Chris Lange | Jun 30, 2016 at 11:39 AM EDT

Bioventus Files for IPO

Bioventus Inc. filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. There were…

Chris Lange | Jun 29, 2016 at 3:34 PM EDT

Lipocine Crashes After Receiving CRL From the FDA

Lipocine Inc. (NASDAQ: LPCN) is watching its shares get cut in half in Wednesday’s session after receiving a letter from…

Chris Lange | Jun 29, 2016 at 1:21 PM EDT

Is Galena Dead in the Water After This Failed Trial?

Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer…

Chris Lange | Jun 29, 2016 at 11:47 AM EDT

Eli Lilly Rises on Positive FDA Committee Vote

Eli Lilly and Co. (NYSE: LLY) is watching its shares make a decent gain on Wednesday following a U.S. Food…

1 … 203 204 205 206 207 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Juno Therapeutics Stumbles Over FDA Clinical Hold

Eleven Biotherapeutics Soars on Investigational Milestone

PTC Therapeutics Wins on New DMD Agreement

Why Flexion Therapeutics Is Adding 3 New Executives to Its Ranks

Do Confidentiality Agreements Signal an Impending Medivation Acquisition?

Amedica Gears Up for Secondary Offering

Insys Soars on Huge FDA Win

4 Companies That Destroyed Shareholders Despite a Brexit Recovery

How Major Pharma Is Faring After the Brexit

Why Array Is Making a Run

Ampio Crashes After Late-Stage Trial Failure

Bioventus Files for IPO

Lipocine Crashes After Receiving CRL From the FDA

Is Galena Dead in the Water After This Failed Trial?

Eli Lilly Rises on Positive FDA Committee Vote

With Consumer Sentiment Near a Record Low, Investors Should Watch This in the Upcoming Reading

Retiree With $48,000 Military Pension and $1.3 Million Slammed By Three Layers of Tax

Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More

Retiree With $48,000 Military Pension and $1.3 Million Slammed By Three Layers of Tax

Medicare Doesn't Cover This $129,000-a-Year Retirement Expense, and Most Find Out Too Late

With Consumer Sentiment Near a Record Low, Investors Should Watch This in the Upcoming Reading

Retiree With $48,000 Military Pension and $1.3 Million Slammed By Three Layers of Tax

Health and Healthcare Articles

All Health and Healthcare Articles

Juno Therapeutics Stumbles Over FDA Clinical Hold

Eleven Biotherapeutics Soars on Investigational Milestone

PTC Therapeutics Wins on New DMD Agreement

Why Flexion Therapeutics Is Adding 3 New Executives to Its Ranks

Do Confidentiality Agreements Signal an Impending Medivation Acquisition?

Amedica Gears Up for Secondary Offering

Insys Soars on Huge FDA Win

4 Companies That Destroyed Shareholders Despite a Brexit Recovery

How Major Pharma Is Faring After the Brexit

Why Array Is Making a Run

Ampio Crashes After Late-Stage Trial Failure

Bioventus Files for IPO

Lipocine Crashes After Receiving CRL From the FDA

Is Galena Dead in the Water After This Failed Trial?

Eli Lilly Rises on Positive FDA Committee Vote

With Consumer Sentiment Near a Record Low, Investors Should Watch This in the Upcoming Reading

Retiree With $48,000 Military Pension and $1.3 Million Slammed By Three Layers of Tax

Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More

Featured Reads

Retiree With $48,000 Military Pension and $1.3 Million Slammed By Three Layers of Tax

Medicare Doesn't Cover This $129,000-a-Year Retirement Expense, and Most Find Out Too Late